Centessa Pharmaceuticals Q4 EPS $(0.38) Beats $(0.48) Estimate
Centessa Pharmaceuticals Q4 EPS $(0.38) Beats $(0.48) Estimate
Centessa Pharmicals第四季度每股收益美元(0.38)超过预期(0.48)
Centessa Pharmaceuticals (NASDAQ:CNTA) reported quarterly losses of $(0.38) per share which beat the analyst consensus estimate of $(0.48) by 20.83 percent. This is a 15.56 percent increase over losses of $(0.45) per share from the same period last year.
Centessa Pharmicals(纳斯达克股票代码:CNTA)公布的季度亏损为每股0.38美元,比分析师普遍预期的0.48美元(0.48美元)高出20.83个百分点。这比去年同期每股亏损0.45美元(0.45美元)增长了15.56%。